申请人:MERCK SHARP & DOHME
公开号:WO2016106625A1
公开(公告)日:2016-07-07
Provided are Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I or pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising these compounds and their use in therapy. In particular, the use of Btk inhibitor compounds of Formula I in the treatment of Btk mediated disorders is provided.